2Rimmele T,Kellum JA. Clinical review:blood purification for sepsis[J]. Crit Care, 2011,15(1) : 205.
3Peng Z,Pai P, Hong-Bao L,et al. The impacts of continuous veno-venous hemofiltration on plasma cytokines and monocyte human leukocyte antigen-DR expression in septic patients[J].Cytokine, 2010,50(2) : 186-191.
4Peng Y, Yuan Z, Li H. Removal of inflammatory cytokines and endotoxin by veno-venous continuous renal replacement therapy for burned patients with sepsis[J]. Bums, 2005,31 (5) : 623-628.
5Klein Klouwenberg PM,Ong DS,Bonten MJ,et al. Classification of sepsis, severe sepsis and septic shock., the impact of minor variations in data capture and definition of SIRS criteria [J]. Intensive Care Med,2012,38(5):811-819.
6Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance[J]. Eur J Immunol,2010,40(7) : 1830-1835.
7Giannoudis PV, Harwood PJ, Loughenbury P, et al. Correla- tion between IL-6 levels and the systemic inflammatory response score: can an IL-6 cutoff predict a SIRS state [J]? J Trauma, 2008,65 (3) : 646-652.
8Popa C,Netea MG,van Riel PL,et al. The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk[J]. J Lipid Res, 2007, 48 (4) : 751- 762.
9Gogos CA, Drosou E, Bassaris HP, et al. Pro-versus anti- inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options[J]. J Infect Dis,2000,181(1) : 176-180.
10Joannidis M. Continuous renal replacement therapy in sepsis and multisystem organ failure[J]. Semin Dial,2009,22(2): 160-164.
